News Sentiment

BDX sentiment intelligence

Becton Dickinson and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 40 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 151.94 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

-3.9% over one week, +3.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Becton Dickinson stock holds steady as medical technology demand underpins long-term growth

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -3.9% Price reacting lower
Trend fit Trend inactive 3.9% over four weeks
Fair value -8.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 18
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Ad Hoc News 5
MarketWatch 4
simplywall.st 4
TradingView 2
Moomoo 2
Investing.com 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 9
Analyst action 4
Macro sensitivity 2
Capital return 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
Ad Hoc News Direct company coverage

Becton Dickinson stock holds steady as medical technology demand underpins long-term growth

Becton Dickinson (ISIN US0718131099) is a global medical technology company whose stock is supported by a diversified portfolio of medical devices and diagnostics. The company's recurring revenue model, driven by essential consumables and instruments, benefits from stable demand

Tone
Positive 75/100
Event
Earnings
Published
16 Jul 2026 10:58
Source
Ad Hoc News
Ad-hoc-news.de Direct company coverage

Becton Dickinson stock holds steady as medical technology portfolio supports long-term growth

Becton Dickinson (BDX) stock remains stable, driven by its diversified medical technology portfolio, which includes devices, diagnostic systems, and bioscience tools. The company's recurring revenue from essential healthcare products, used daily in hospitals and labs, provides st

Tone
Positive 72/100
Event
Earnings
Published
15 Jul 2026 11:47
Source
Ad-hoc-news.de
TradingView Direct company coverage

BDX.GE Bond Profile — Key Metrics

This article provides a bond profile for Becton, Dickinson and Company's 6.7% 01-AUG-2028 bond (BDX.GE). It details key metrics such as the issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also includes a description of Becton, Dickinson & Co

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 20:07
Source
TradingView
MarketWatch Direct company coverage

Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors

Shares of Becton Dickinson & Co. (BDX) fell by 2.07% on Tuesday, closing at $150.65, despite an overall positive trading session for the broader market indices, including the S&P 500 and Dow Jones Industrial Average. This decline ended a three-day winning streak for the stock.

Tone
Negative 29/100
Event
Market update
Published
14 Jul 2026 16:51
Source
MarketWatch
Moomoo Direct company coverage

Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating

Goldman Sachs has updated its price target for Becton, Dickinson and Company (BDX) from $150 to $152. The firm has decided to maintain its Neutral rating on the stock despite the slight increase in the price target. This adjustment reflects Goldman Sachs' current outlook on the c

Tone
Neutral 50/100
Event
Analyst action
Published
14 Jul 2026 14:37
Source
Moomoo
MarketWatch Direct company coverage

Becton Dickinson & Co. stock outperforms competitors on strong trading day

Shares of Becton Dickinson & Co. (BDX) rose 1.24% to $153.83 on Monday, outperforming the broader market, which saw declines in the S&P 500 and Dow Jones Industrial Average. This marks the third consecutive day of gains for the stock.

Tone
Positive 71/100
Event
Market update
Published
13 Jul 2026 16:53
Source
MarketWatch
R&D World Direct company coverage

Inside BD's plan to forecast hospital drug demand with AI while keeping models within bounds

Becton, Dickinson and Company (BD) is leveraging its Incada Connected Care Platform to develop an AI-enabled strategy for forecasting hospital drug demand, aiming to optimize medication inventory and reduce waste. Omar Ahmed, SVP of R&D for BD's Connected Care segment, emphasizes

Tone
Positive 70/100
Event
Guidance
Published
09 Jul 2026 22:07
Source
R&D World
TradingView Direct company coverage

BD to Announce Financial Results for its Third Quarter of Fiscal 2026

BD (Becton, Dickinson and Company) announced it will host an audio webcast on Thursday, August 6, 2026, at 8 a.m. ET to discuss its financial results for the third quarter of fiscal year 2026, which concluded on June 30, 2026. The webcast will provide an update on the company's o

Tone
Neutral 50/100
Event
Earnings
Published
09 Jul 2026 19:53
Source
TradingView
BD Newsroom Direct company coverage

BD Named to TIME’s 2026 List of America’s Best Companies

BD (Becton, Dickinson and Company) has been recognized by TIME as one of America's Best Companies for 2026. This esteemed list is generated through a data-driven evaluation focusing on employee satisfaction, financial performance, and corporate sustainability. The achievement hig

Tone
Positive 73/100
Event
Market update
Published
09 Jul 2026 18:07
Source
BD Newsroom
GuruFocus Direct company coverage

Waters Corporation (WAT) Gains as RBC Initiates Coverage with Outperform Rating

Waters Corporation (WAT) saw its stock rise after RBC Capital Markets initiated coverage with an Outperform rating and a $435 price target, highlighting the potential for revitalization of recently acquired units from Becton, Dickinson. The company boasts a strong GF Score™ of 94

Tone
Positive 67/100
Event
Analyst action
Published
09 Jul 2026 18:06
Source
GuruFocus
Investing.com Direct company coverage

RBC Capital initiates Waters stock coverage with outperform rating

RBC Capital has initiated coverage on Waters Corp. (NYSE:WAT) with an "outperform" rating and a price target of $435.00, citing the turnaround opportunity in recently acquired Becton Dickinson businesses and Waters' emerging role as a sector consolidator. The

Tone
Positive 62/100
Event
Analyst action
Published
09 Jul 2026 10:43
Source
Investing.com
Sahm Direct company coverage

Becton Dickinson (BDX) Following Its Veritor Shift And Index Changes Looks Undervalued

Becton Dickinson (BDX) is seen as undervalued despite mixed performance, including a recent share price decline, following its request for FDA revocation of the Emergency Use Authorization for its Veritor SARS-CoV-2 test and index reshuffles. The company's fair value is estimated

Tone
Positive 75/100
Event
Market update
Published
09 Jul 2026 00:37
Source
Sahm
AlphaStreet Direct company coverage

Becton, Dickinson (BDX) Has a Recurring Workflow Engine Bigger Than a Broad MedTech Label

Becton, Dickinson (BDX) should be viewed differently by investors than a typical MedTech company due to its significant recurring revenue streams derived from daily care workflows rather than one-off equipment sales. The company's focus on medication management, specimen collecti

Tone
Positive 72/100
Event
Earnings
Published
08 Jul 2026 22:37
Source
AlphaStreet
MarketWatch Direct company coverage

Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors

Becton Dickinson & Co. (BDX) stock fell 3.67% to $150.56 on Wednesday, underperforming the broader market which also saw declines in the S&P 500 and Dow Jones Industrial Average. The company's stock closed 19.64% below its 52-week high reached in February. This performance highli

Tone
Negative 30/100
Event
Market update
Published
08 Jul 2026 16:50
Source
MarketWatch
Market source Direct company coverage

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

Becton Dickinson (BDX) is poised to potentially beat its upcoming earnings estimates, according to Zacks Investment Research. The company has a strong history of topping earnings, with an average surprise of 3.94% over the last two quarters. Its positive Zacks Earnings ESP of +2.

Tone
Positive 72/100
Event
Earnings
Published
08 Jul 2026 16:37
Source
Market source
AD HOC NEWS Direct company coverage

Becton Dickinson stock holds steady. Focus shifts to business model.

Becton Dickinson (BDX) stock maintains stability, with the company's core business centered on medical technology products like medication delivery systems, specimen collection tools, and diagnostic equipment. The article emphasizes that BD's financial performance is more influen

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 09:38
Source
AD HOC NEWS
Moomoo Direct company coverage

Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190

Evercore ISI has revised its price target for Becton, Dickinson and Company (BDX) from $190 down to $180. The firm has maintained its Outperform rating on the stock. This adjustment reflects a change in the analyst's valuation perspective for the company.

Tone
Negative 39/100
Event
Analyst action
Published
06 Jul 2026 17:07
Source
Moomoo
MarketWatch Direct company coverage

Becton Dickinson & Co. stock outperforms competitors despite losses on the day

Shares of Becton Dickinson & Co. (BDX) fell 1.61% to $155.54 on Monday, breaking a two-day winning streak. This occurred despite an overall positive trading session that saw the S&P 500 Index and the Dow Jones Industrial Average both rise. The article highlights how the stock per

Tone
Negative 39/100
Event
Market update
Published
06 Jul 2026 16:52
Source
MarketWatch